Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
P
Pantelis Nicola
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
2.0K
Citations
10
h-index
10
i10-index
Pantelis Nicola is an academic researcher from Wellcome Sanger Institute. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & COVID-19 Clinical Research Studies. The author has an h-index of 10, co-authored 28 publications.
ORCID: 0000-0002-8641-3580Papers by this author
worksConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 289 citations
https://doi.org/10.1016/s0140-6736(21)01825-0
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · The Lancet Child & Adolescent Health · 33 citations
https://doi.org/10.1016/s2352-4642(23)00316-4
Somatic mutation and selection at population scale
2025 · Nature · 21 citations
https://doi.org/10.1038/s41586-025-09584-w
Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1
2025 · Nature Genetics · 7 citations
https://doi.org/10.1038/s41588-025-02097-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat